Zelig Eshhar, Who Engineered Immune Cells to Fight Cancer, Dies at 84

Entrepreneurs Press Magazine

He made a conceptual leap in immunotherapy by creating a hybrid T-cell, known as CAR-T, that was genetically modified to destroy cancer cells.He made a conceptual leap in immunotherapy by creating a hybrid T-cell, known as CAR-T, that was genetically modified to destroy cancer cells. Read More

Leave a Comment

Your email address will not be published. Required fields are marked *